The Structure, Expression, and Function Prediction of DAZAP2, A Down-Regulated Gene in Multiple Myeloma  by Shi, Yiwu et al.
Letter
The Structure, Expression, and Function Prediction of DAZAP2, A
Down-Regulated Gene in Multiple Myeloma
Yiwu Shi1, Saiqun Luo1, Jianbin Peng2, Chenghan Huang2, Daren Tan3, and Weixin Hu1*
1Molecular Biology Research Center, Xiangya Medical College, Central South University, Changsha 410078,
China; 2Laboratory of Biochemistry and Molecular Genetics, Lindsley F. Kimball Research Institute, New York
Blood Center, New York 10021, USA; 3Department of Hematology of Xiangya Hospital, Changsha 410078,
China.
In our previous studies, DAZAP2 gene expression was down-regulated in untreated
patients of multiple myeloma (MM). For better studying the structure and function
of DAZAP2, a full-length cDNA was isolated from mononuclear cells of a normal
human bone marrow, sequenced and deposited to Genbank (AY430097). This se-
quence has an identical ORF (open reading frame) as the NM 014764 from human
testis and the D31767 from human cell line KG-1. Phylogenetic analysis and struc-
ture prediction reveal that DAZAP2 homologues are highly conserved throughout
evolution and share a polyproline region and several potential SH2/SH3 binding
sites. DAZAP2 occurs as a single-copy gene with a four-exon organization. We fur-
ther noticed that the functional DAZAP2 gene is located on Chromosome 12 and
its pseudogene gene is on Chromosome 2 with electronic location of human chro-
mosome in Genbank, though no genetic abnormalities of MM have been reported
on Chromosome 12. The ORF of human DAZAP2 encodes a 17-kDa protein,
which is highly similar to mouse Prtb. The DAZAP2 protein is mainly localized in
cytoplasm with a discrete pattern of punctuated distribution. DAZAP2 may as-
sociate with carcinogenesis of MM and participate in yet-to-be identified signaling
pathways to regulate proliferation and differentiation of plasma cells.
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Introduction
Given that there is a large amount of data on the se-
quence of new genes whose functions are yet unknown
in public databases, and hence a great challenge to re-
searchers in the functional study, bioinformatics has
become a powerful tool for predicting gene’s function.
Gene expression patterns in diseases (including can-
cer) in combination with special analytical software
do give scientists directions for further research in ac-
quiring functional information of new genes. Multi-
ple myeloma (MM) is a disorder characterized by the
uncontrolled proliferation and accumulation of ma-
lignant plasma cells in the bone marrow (1 ). To
identify the MM-associated genes and delineate their
pathogenic correlation, we used cDNA profiling to




mononuclear cells from MM patients and normal sub-
jects. The levels of the most significantly down-
regulated gene DAZAP2 (deleted in azoospermia as-
sociated protein 2; ref. 2) were verified by Western
blotting analysis of MM samples (7/11 or 63.6%),
but all normal subjects (control) expressed DAZAP2
(3 ). DAZAP2 expression at both the mRNA and pro-
tein levels was negatively correlated with the patho-
genesis of MM. The DAZAP2 protein had originally
been identified as an interacting protein of germ-
cell-specific RNA-binding proteins DAZ (deleted in
azoospermia; ref. 4). The published DAZAP2 cDNA
comes from a human testis cDNA library, located on
Chromosome 2 with unknown function (4 ). To ex-
plore the functional significance of the down-regulated
DAZAP2 gene in MM, we isolated this gene, charac-
terized its product from human bone marrow mononu-
clear cells of a normal subject, and searched the avail-
able databases. By suitable software, we identified its
homologues and characterized its molecular phyloge-
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nies. Since the positions of functional and/or struc-
tural importance tend to be more conserved in evo-
lution, we may find important functional region of
DAZAP2 by amino acid sequence alignment of 15
vertebrates’ DAZAP2 proteins. Furthermore, the ex-
pression pattern of DAZAP2 may also provide hints
of its function. All these analyses tried to shed new
light on the function of the DAZAP2 gene.
Results
Sequence analysis, molecular phylogeny
and genomic organization of DAZAP2
A full-length DAZAP2 cDNA was isolated from
mononuclear cells of normal human bone marrow, se-
quenced and deposited to Genbank (AY430097). Fig-
ure 1 shows its nucleotide and predicted amino acid
sequence. The DAZAP2 gene contains a short 5′
UTR, an ORF (open reading frame) from Nucleotides
84–590, and a relatively long 3′ UTR plus poly(A)
tail. Its ORF is predicted to encode a 17-kDa protein
with 168 amino acids and is the same as those of the
DAZAP2 gene (NM 014764) from human testis (4 )
and D31767 (KIAA0058) from human cell line KG-1
(5 ). Human DAZAP2 is highly similar to mouse Prtb
(proline codon-rich transcript, brain expressed; ref.
6). Further sequence analysis reveals that DAZAP2
contains a proline-rich region and several potential
SH2 (YxxΨ) and SH3 (PxΨP) domain-binding mo-
tifs.
Fig. 1 The nucleotide and predicted amino acid sequence of DAZAP2. The cDNA was cloned from total RNA of
mononuclear cells of normal bone marrow. The polyproline region is shown by a rectangle. Potential SH2 (YxxΨ) and
SH3 (PxΨP) domain-binding motifs are underlined. The initiation and stop codons are in bold. Triangles denote exon
boundaries. The 3′-polyadenylation signals are underlined.
As shown in Figure 2A, human DAZAP2 has a
highly related gene in two distant species, Apis mellif-
era (B1515614) and Ciona intestinalis (AY490098).
This gene is highly conserved in vertebrates from
zebrafish to human being whose homologues show
a slow evolution. Comparison of 15 vertebrates’
DAZAP2 (Genbank IDs: AU297060, CB553719,
XM 217038, NM 011873, BM967886, CD051977,
CD467315, CD728885, AY490096, BC042215,
BX078169, CB516510, AY490097, and BC059628)
reveals that the polyproline region is a conserved
structural motif (Figure 2B). Notably, its C-terminus
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Fig. 2 Phylogenetic analysis and sequence alignment of DAZAP2. A. The tree topologies. The branch lengths,
estimated by ML methods, denote nucleotide substitutions per nucleotide sites. The numbers on nodes are bootstrap
test values. Left : ML at 1,000 puzzling steps for protein sequences under HKY85 model with five categories of Gamma
substitution rate plus invariable sites (5G+I); Middle: ML at 1,000 puzzling steps for nucleotide sequences under JTT
model with 5G+I; Right : MP at 200 replicates for protein sequences under default parameters. GenBank accession
numbers are given along the tree. B. Sequence alignment of vertebrate DAZAP2 proteins. Dashes denote gaps or
missing residues. The bold amino acids at the bottom represent 90% consensus in the alignment. The 17 prolines are
largely conserved and the N-terminus is less conserved than the C-terminus. The single α-helix (underlined) present in
the C-terminal end is flanked by potential extended β-sheets (not shown).
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is more conserved than its N-terminus.
Genomic analysis by database searching
(www.ncbi.nlm.nih.gov) showed that DAZAP2 oc-
curs as a single-copy gene with a four-exon organiza-
tion conserved throughout vertebrate evolution (Fig-
ure 3A). By electronic location of human chromosome
in Genbank, we further noticed that the functional
DAZAP2 gene is located on human Chromosome 12
rather than Chromosome 2 that had been reported
(4 ). By comparing the DAZAP2 with its homologue
sequence on Chromosome 2, we identified that the
latter is a pseudogene that contains no introns but
processed poly(A) tails and nonsense mutation that
inactivates its protein expression (Figure 3B).
Fig. 3 Genomic organization of DAZAP2 and its nucleotide sequence alignment with the pseudogene. A. The
structure of four exons in human and pufferfish and five exons in sea squirt. The ATG initiation codon and stop
codon are illustrated. The lengths of every exon (open bars) and intron (straight lines) are shown by the amount of
base pairs. Note that rat, mouse and frog have the same gene organization as fish and human. B. The alignment
between human DAZAP2 and pseudogene (ϕ). Nucleotide changes are spelled out. Dots denote identity and dashes
denote deletion. For the wild-type gene, the initiation (M) codon and stop signals are in bold. For the pseudogene, the
nonsense mutation TAG is bold, and the 311-bp and 321-bp insertion sequences are omitted.
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DAZAP2 expression in human tissues
To define the pattern of DAZAP2 expression in var-
ious tissues, a human multiple tissue Northern blot
was performed. As shown in Figure 4, DAZAP2 is
expressed as a 1.9-Kb transcript in seven normal hu-
man tissues, including stomach, thyroid, spinal cord,
lymph node, trachea, adrenal gland, and bone mar-
row. The results indicate a ubiquitous expression of
the DAZAP2 gene in vivo and suggest an important
functional role of the DAZAP2 gene in multiple tis-
sues.
Fig. 4 Expression of DAZAP2 in human tissues. A
human multiple tissue Northern blot was hybridized with
a DAZAP2 cDNA probe. Lane M: size markers. Lanes
1-7: stomach, thyroid, spinal cord, lymph node, trachea,
adrenal gland, and bone marrow. A single and abundant
transcript of about 1.9 Kb is seen in all tissues. The inten-
sity of β-actin mRNA bands was relatively constant (not
shown).
Expression and intracellular localiza-
tion of DAZAP2 protein
To verify the expression of DAZAP2 protein in eu-
karyotic cells, pEGFP-N1-DAZAP2 was transfected
into COS7 cells. Western-blotting analysis detected a
44-kDa protein in cells transfected with pEGFP-N1-
DAZAP2 and a 27-kDa protein in cells transfected
with pEGFP-N1 alone by using an anti-GFP anti-
body. Thus, the DAZAP2 protein expressed in COS7
cells was about 17-kDa (Figure 5), a result that is
consistent with ORF prediction and Western blot of
native DAZAP2 protein expressed in the bone mar-
row (data not shown).
The intracellular localization of DAZAP2 protein
was next examined by immunofluorescent microscopy.
In control cells expressing GFP alone, the green fluo-
rescence was distributed evenly in the cytosol and
Fig. 5 Immunoblotting analysis of the fusion protein
DAZAP2-EGFP expression. Lane 1: EGFP protein; the
MW (molecular weight) of EGFP protein is about 27
kDa. Lane 2: DAZAP2-EGFP fusion protein; the MW
of DAZAP2-EGFP fusion protein is about 44 kDa.
in the nucleus (Figure 6A). By contrast, COS7 cells
expressing DAZAP2-GFP showed a largely cytoso-
lic location with small distinctive punctated stain-
ing (Figure 6B, green color). The green fluorescence
of DAZAP2-GFP fusion protein showed no apparent
overlap with the staining of Golgi (Figure 6B, red
color), indicating that DAZAP2 protein mainly re-
sides in the cytoplasm with a discrete pattern of punc-
tated structures.
Discussion
Multiple myeloma is a malignant disorder of plasma
cells for which the molecular etiology is still unknown
(1 ). The fact that the down-regulation of DAZAP2
occurred at both the mRNA (2 ) and protein levels
(3 ) provides a strong indication for its specific as-
sociation with MM. A full-length 1,913 bp DAZAP2
cDNA (AY430097) isolated from human bone mar-
row mononuclear cells has an identical ORF as the
published DAZAP2 from human testis library and
KG-1 cell line. To explore the sequence features and
functional significance of DAZAP2, we searched avail-
able databases and used three program packages and
methods to identify its homologues and characterize
its molecular phylogenies. A more detailed picture
of DAZAP2 molecular evolution was obtained when
we isolated three closely related cDNA fragments
of DAZAP2 from three distant species (AY490096,
AY490097, AY490098). The three program pack-
ages and methods we employed are TREE-PUZZLE,
MEGA2 and T-coffee. TREE-PUZZLE is a quartet-
based maximum-likelihood phylogenetic analysis tool,
including a broad variety of evolutionary models (7 ),
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Fig. 6 Intracellular localization of DAZAP2 protein. COS7 cells were transfected with either pEGFP vector or
DAZAP2-GFP plasmid and visualized under confocal microscopy. A. Expression of GFP in control cells. Note the
green fluorescence of GFP is evenly distributed in the cytosol and the nucleus. B. The DAZAP2-GFP fusion protein
(green) shows largely a cytosolic distribution with small discrete punctuated staining; its green fluorescence appears
not to overlap with the staining of Golgi (red).
for example, models for DNA sequences (TN, ref. 8),
models for protein sequences (JTT and VT, ref. 9,
10). MEGA2 is a set of software that can compute
evolutionary distances based on the observed differ-
ences in amino acid and nucleotide sequences (11 ).
The bootstrap test and the interior branch length
tests can examine the reliability of the inferred phylo-
genies (12 , 13 ). Most of the bootstrap test values on
nodes of the tree topologies have a high score (Figure
2A), which elucidate the accuracy of the phylogenetic
tree (14 ). From the result of the phylogenetic tree, in
which human DAZAP2 has a highly related gene in
two distant species, Apis mellifera and Ciona intesti-
nalis, we concluded that DAZAP2 has an early origin.
This suggests that DAZAP2 might have vital cellular
functions. T-coffee is a method for multiple alignment
that provides a dramatic improvement in accuracy,
and its resulting alignments are significantly more re-
liable as compared to the most commonly used alter-
natives (15 ). By this reliable method, we showed that
DAZAP2 was conserved throughout evolution, partic-
ularly in the C-terminus of the protein we defined a
potentially important function domain for DAZAP2.
Its vertebrate homologues virtually carried the same
genomic organization and structural features (four ex-
ons and three introns; the others are 5′ and 3′ un-
translated regions). Moreover, by nucleotide sequence
alignment, we found that human has a functional gene
on Chromosome 12 and its pseudogene on Chromo-
some 2, yet Chromosome 12 has not been implicated
to harbor MM-associated gene abnormalities (1 , 16 ).
The pseudogene protein expression was inactivated
by a nonsense mutation (substitution TAG for TAC).
Structure prediction revealed multiple sequence mo-
tifs in DAZAP2 including several potential SH2 and
SH3 binding sites, which also conserved throughout
evolution. Protein-protein interactions mediated by
SH2 and SH3 domains have been shown to play a
central role in multiple signaling pathways that reg-
ulate cell proliferation and differentiation (17 ). For
instance, the SH3-SH2-SH3 Grb2 adapter links the
receptors to the Ras pathway (18 ); Nck/Dock, com-
posed of three SH3 domains and one SH2 domain,
links cell surface receptors to the actin cytoskeleton
(19 ). Hence, it is of great interest to uncover the role
of DAZAP2 in such signaling events in regulating the
proliferation of tumor cells in MM, should the dis-
ruption of these interactions result in loss-of-function
phenotypes.
As shown here and elsewhere (4 , 5 ), DAZAP2 was
broadly expressed in normal tissues and cell lines.
Given this ubiquitous occurrence of DAZAP2 and
testis specificity of DAZ, their interaction is unlikely
to play a critical role in the pathogenesis of MM, al-
though the expression of DAZ was not assessed. It
is of further interest to note the mouse homologue
Prtb, which was first cloned from mouse brain (6 ) and
located in the cytoplasm (20 ). Its expression is in-
creased in osteoclast cell line (MC3P3-E1) upon adhe-
sion to polystyrene with or without surface-adsorbed
serum proteins, suggesting that Prtb is involved in cell
adhesion-mediated function (20 ). The human 17-kDa
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DAZAP2 protein was also mainly localized in cyto-
plasm as mouse Prtb protein. Nevertheless, whether
human DAZAP2 and mouse or rat Prtb genes are
functionally equivalent in the setting of MM patho-
genesis and progression remains to be elucidated.
Materials and Methods
Bone marrow sample
Normal control bone marrow samples were obtained
from the Department of Hematology of Xiangya Hos-
pital, Central South University, China.
Total RNA preparation
Mononuclear cells were isolated from bone marrow
samples by the lymphocyte isolation solution. Total
RNA was prepared from the bone marrow mononu-
clear cells using Trizol kit (Invitrogen, Carlsberg,
USA). RNA concentration was determined on a UV
spectrophotometer. The quality of RNA was assessed
by electrophoresis on 1.2% agarose gel.
Isolation and sequencing of DAZAP2
cDNA from bone marrow
Based on the sequence of DAZAP2, gene-specific
primers (GSPs) in either sense (S) or antisense (A)
were designed to isolate the DAZAP2 gene from
mononuclear cells of bone marrow of normal con-
trol by the method of rapid amplification of cDNA
ends (RACE). For the 5′ RACE, 2.5 µg of total
RNA was reverse-transcribed with the 5′-end phos-
phorylated GSP (RT1): 5′-ACAACATGTGTCT-3′.
The RNA strand of DNA-RNA duplex was digested
and the single cDNA strand was circularized as de-
scribed in the 5′-Full RACE kit (TaKaRa Bio Inc.,
Dalian, China) (21 ). The cDNA was then ampli-
fied sequentially with two different pairs of GSPs
as follows: S1, 5′-GGTATGATGCAGGTGCCAG-
3′/A1, 5′-GACCGACTGGATAAT-3′; and S2, 5′-
CGTCCTCGTAACTCAGCGG-3′/A2, 5′-GATACA
GAGAAACTACAGG-3′. For the 3′ RACE, 1.0 µg
of total RNA was reverse-transcribed with sup-
plied oligo dT-3 sites adapter primer, and then
amplified once with adapter primer 5′-CTGATC
TAGAGGTACCGGATCC-3′ and GSP (S3), 5′-
GGTGGCTACACCATCTGGTG-3′, as described in
the 3′-Full RACE kit (TaKaRa Bio Inc.). PCR prod-
ucts were analyzed on 1.5% agarose gel. The 5′
and 3′ RACE products were purified, subcloned into
the pEGM-Teasy vector (Promega, San Luis Obispo,
USA), and then sequenced on an automated ABI377
sequencer.
Sequence analysis, structure prediction
and phylogenetic analysis
Sequence analysis and structural prediction were per-
formed by searching public databases on the web-
site servers of NCBI (http://www.ncbi.nlm.nih.gov/
BLAST/), NetStar (http://www.cbs.dtu.dk/services)
and Scan Prosite (http://us.expasy.org/cgi-bin/scan
prosite). The tree topologies were estimated using
maximum likelihood (ML; ref. 7) and maximum par-
simony (MP; ref. 11). The sequence alignment was
carried out using T-coffee (15 ) followed by manual
inspection.
Analysis of DAZAP2 expression in hu-
man tissues
The human multiple tissue Northern blot with
poly(A)+ RNA prepared from various tissues (Clon-
tech, Palo Alto, USA) was hybridized with the 32P-
labeled DAZAP2 cDNA probe. The probe spans the
entire ORF of DAZAP2. Human β-actin cDNA was
used as a control probe. The blot was hybridized and
washed under highly stringent conditions.
Transfection, immunoblotting and im-
munolocalization
The recombinant pEGFP-DAZAP2 expression vec-
tor was constructed as follows. The primers for
DAZAP2 amplification were 5′-CGGAATTCGCC
GCCACCATGAACAGCAAAGGTC-3′ (sense) and
5′-GCGGATCCCGCCAGATGGTGTAGCCACCA
TC-3′ (antisense), which contain EcoR I and BamH
I sites (in bold), respectively. The ORF of DAZAP2
was amplified by PCR using the cDNA template de-
rived from mononuclear cell RNA of normal bone
marrow. PCR products were digested with EcoR
I and BamH I followed by ligation to the pEFGP-
N1 vector (Clontech) and transformation into E. coli
DH5α cells. The ORF and fusion with the GFP gene
in the pEGFP-N1-DAZAP2 vector were verified by
EcoR I and BamH I digestion followed by DNA se-
quencing.
COS7 cells (ATCC) were used as a host for
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DAZAP2-GFP fusion protein expression. Transfec-
tion was performed with LipofectAMINE-2000 using
the manufacturer’s protocol (Invitrogen, Carlsbad,
USA). For immunoblotting analysis, cells were seeded
in a 3-cm dish, transfected with DAZAP2-GFP plas-
mid and cultured for 24 h. The cells were lysed
and the total proteins (10 µg) were separated on
a 4%-20% precast Tris-glycine gel, and were then
electro-transferred to PVDF (polyvinylidene difluo-
ride) membranes. The protein bands were visual-
ized by using an ECL-plus kit (Amersham, Piscat-
away, USA). Immunostaining was done as above with
the primary anti-GFP antibody (Clontech; ref. 22).
Briefly, cells grown on coverslips were fixed with 3.7%
paraformadelhyde for 30 min, permeated with 0.1%
Triton X-100 for 10 min, and immunostained with the
respective antibodies for 1 h after blocking with 5%
BSA (bovine serum albumin) for 30 min. Cells were
then stained with cy2- or cy3-labeled secondary anti-
bodies (The Jackson Laboratory, Bar Harbor, USA).
After several times of washing in PBS (phosphate-
buffered saline), coverslips were mounted on slides
with anti-fade buffer and observed under confocal
microscopy.
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